Application of the ESTRO/EORTC oligometastatic disease classification system to current evidence

With increasing interest in stereotactic body radiotherapy (SBRT) for treatment…" />

We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.